Multifunctional silica nanocomposites prime tumoricidal immunity for efficient cancer immunotherapy
Linnan Yang(Shanghai First Maternity and Infant Hospital), Ang Li(Baylor College of Medicine)
Cited by 33
Related Papers
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple Myeloma
|Journal of the National Comprehensive Cancer Network|2019|146
Synergetic Functional Nanocomposites Enhance Immunotherapy in Solid Tumors by Remodeling the Immunoenvironment
|Advanced Science|2019|99
Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial
|Journal of Clinical Oncology|2024|43
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19
|Journal of Thrombosis and Haemostasis|2021|30